RESA_PLAFN
ID RESA_PLAFN Reviewed; 760 AA.
AC P13831;
DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1990, sequence version 1.
DT 25-MAY-2022, entry version 98.
DE RecName: Full=Ring-infected erythrocyte surface antigen;
DE Flags: Fragment;
GN Name=RESA;
OS Plasmodium falciparum (isolate NF7 / Ghana).
OC Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX NCBI_TaxID=5842;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=6085696;
RA Cowman A.F., Coppel R.L., Saint R.B., Favaloro J., Crewther P.E.,
RA Stahl H.-D., Bianco A.E., Brown G.V., Anders R.F., Kemp D.J.;
RT "The ring-infected erythrocyte surface antigen (RESA) polypeptide of
RT Plasmodium falciparum contains two separate blocks of tandem repeats
RT encoding antigenic epitopes that are naturally immunogenic in man.";
RL Mol. Biol. Med. 2:207-221(1984).
CC -!- FUNCTION: May disrupt the normal intermolecular interactions of the
CC cytoplasmic domain of band 3 and thereby facilitate the invagination of
CC the red cell membrane which is necessary for the formation of the
CC parasitophorous vacuole.
CC -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein;
CC Cytoplasmic side. Note=Probably located on the cytoplasmic face of the
CC membrane where it associates with components of the membrane skeleton.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X05181; CAA28816.1; -; mRNA.
DR AlphaFoldDB; P13831; -.
DR SMR; P13831; -.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR CDD; cd06257; DnaJ; 1.
DR Gene3D; 1.10.287.110; -; 1.
DR Gene3D; 6.10.280.180; -; 1.
DR InterPro; IPR001623; DnaJ_domain.
DR InterPro; IPR018253; DnaJ_domain_CS.
DR InterPro; IPR026894; DnaJ_X.
DR InterPro; IPR036869; J_dom_sf.
DR InterPro; IPR019111; PRESA_N.
DR InterPro; IPR044885; PRESA_N_sf.
DR Pfam; PF00226; DnaJ; 1.
DR Pfam; PF14308; DnaJ-X; 1.
DR Pfam; PF09687; PRESAN; 1.
DR PRINTS; PR00625; JDOMAIN.
DR SMART; SM00271; DnaJ; 1.
DR SUPFAM; SSF46565; SSF46565; 1.
DR PROSITE; PS00636; DNAJ_1; 1.
DR PROSITE; PS50076; DNAJ_2; 1.
PE 2: Evidence at transcript level;
KW Cell membrane; Glycoprotein; Malaria; Membrane.
FT CHAIN <1..>760
FT /note="Ring-infected erythrocyte surface antigen"
FT /id="PRO_0000071160"
FT DOMAIN 307..375
FT /note="J"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00286"
FT REGION 214..300
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 683..738
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 216..230
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 231..291
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 689..717
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 718..738
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 425
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 559
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 563
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT NON_TER 1
FT NON_TER 760
SQ SEQUENCE 760 AA; 88585 MW; 8D1F28D76AB200FF CRC64;
EFRYSQYKVQ YDMPKEAYES KWTQCIKLID QGGENLEERL NSQFKNWYRQ KYLNLEEYRR
LTVLNQIAWK ALSNQIQYSC RKIMNSDISS FKHINELKSL EHRAAKAAEA EMKKRAQKPK
KKKSRRGWLC CGGGDIETVE PQQEEPVQTV QEQQVNEYGD ILPTLRASIT NSAINYYDTV
KDGVYLDHET SDALYTDEDL LFDLEKQKYM DMLDTSQEES VEENEEEHTV DDEHVEEHTA
DDEHVEEPTV ADDEHVEEPT VADEHVEEPT VAEEHVEEPT VAEEHVEEPA SDVQQTSEAA
PTIEIPDTLY YDILGVGVNA DMNEITERYF KLAENYYPYQ RSGSTVFHNF RKVNEAYQVL
GDIDKKRWYN KYGYDGIKQV NFMNPSIFYL LSSLEKFKDF TGTPQIVTLL RFFFEKRLSM
NDLENKSEHL LKFMEQYQKE REAHVSEYLL NILQPCIAGD SKWNVPIITK LEGLKGSRFD
IPILESLRWI FKHVAKTHLK KSSKSAKKLQ QRTQANKQEL ANINNNLMST LKEYLGSSEQ
MNSITYNFEN INSNVDNGNQ SKNISDLSYT DQKEILEKIV SYIVDISLYD IENTALNAAE
QLLSDNSVDE KTLKKRAQSL KKLSSIMERY AGGKRNDKKA KKYDTQDVVG YIMHGISTIN
KEMKNQNENV PEHVQHNAEA NVEHDAEENV EHDAEENAEE NVEENVEEVE ENVEENVEEN
VGEKKMRREE KKKRVQEPIK IDEIQVYDII KNEKKKKTEF